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Dear Editor,
We read with interest the article “Role of high-dose 
hydrochlorothiazide in idiopathic hypercalciuric 
urolithiasis of childhood” by Naseri and Sadeghi.1 
They used high-dose hydrochlorothiazide (1 mg/
kg/d to 2 mg/kg/d) in hypercalciuric children and 
described that no study has addressed whether 
low doses of thiazides have a hypocalciuric effect, 
especially in children.1 We recently reported that 
a low dose (0.5 mg/kg/d) of hydrochlorothiazide 
may be safe and effective in controlling renal 
hypercalciuria in children and found that hematuria 
and urolithiasis gradually resolved in accordance 
with the improvement of hypercalciuria.2
Although Naseri and Sadeghi did not mention 
the mechanisms action of hydrochlorothiazide,1 
extracellular volume contraction resulting in a 
compensatory increase in renal proximal sodium 
reabsorption with passive paracellular calcium 
reabsorption3 and transient receptor potential 
vanil loid 5 (TRPV5)4, 5 might be important 
in understanding the hypocalciuric effect of 
hydrochlorothiazide. Hoenderop and colleagues4 
showed active calcium reabsorption in the distal 
convoluted tubule was completely abolished in 
TRPV5 knockout mice, and Jang and colleagues5 
recently demonstrated that the hypocalciuric effect 
of hydrochlorothiazide might be associated with 
increased protein abundance of TRPV5 in high-
salt or calcium-diet-induced hypercalciuric rats.
Therefore, we speculate that the degree of response 
to hydrochlorothiazide might be different in relation 
to not only dietary factors such as sodium intake, 
but also TRPV5-related mechanisms. Further studies 
are necessary to evaluate the role of TRPV5 in 
children with idiopathic hypercalciuria and elucidate 
whether there is a relationship between the dose 
of hydrochlorothiazide and abundance of TRPV5. 
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REPLY BY AUTHORS
Dear Editor, 
Choi and colleagues retrospectively analyzed 
idiopathic hypercalciuria in 28 children to evaluate 
therapeutic effect of hydrochlorothiazide.1 They 
used a low dose of the drug (0.5 mg/kg) in 
patients who mostly did not have nephrolithiasis. 
Thiazide diuretics are usually recommended in 
cases of hypercalciuria associated with urolithiasis, 
nephrocacinosis,  or osteoporosis.  Choi and 
colleagues, however, used hydrochlorothiazide 
in patients who had urinary tract infection or 
hematuria due to hypercalciuria. In their series, 
hypercalciuria was accompanied by nephrolithiasis 
in 6 patients (21%), and the majority of their 
cases had hematuria. They found that low-dose 
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hydrochlorothiazide induced normal urinary 
calcium excretion in the majority of patients (89%) 
and 11% needed high doses of the drug to reach 
normal urinary calcium excretion. 
I  think our study2 differs from Choi and 
colleagues’ study1 in several ways which caused 
different conclusions. The main differences 
between these two studies are as follows: (1) 
Choi and colleagues evaluated hypocalciuric role 
of hydrochlorothiazide in patients with different 
complications of hypercalciuria, while we studied 
the effect of hydrochlorothiazide in children 
with hypercalciuria and nephrolithiasis. (2) We 
defined response to treatment as normal urinary 
calcium excretion rate accompanied with decreased 
calculus size or a calculus-free condition. Choi and 
colleagues defined it as reaching normal urinary 
calcium excretion rate. (3) Idiopathic hypercalciuria 
is worsened by a diet high in sodium and animal 
protein. Thiazide diuretics lower urinary calcium 
excretion and promote mineral retention. Therefore, 
treatment of idiopathic hypercalciuria consists 
of high fluid intake, dietary sodium restriction, 
and thiazide diuretics.3 In addition to the role 
of diet in pathogenesis of calculus formation, 
nutritional factors such as fluid and sodium intake 
undoubtedly play important roles in response 
to hydrochlorothiazide. Neither of the studies 
analyzed amount of fluid and sodium intake, and 
thus, differences in these parameters could affect 
the results. (4) Another factor that could affect the 
results is the severity of hypercalciuria. Odvina 
and colleagues4 studied 131 patients with proven 
primary hyperparathyroidism and found that 
patients who had calculi excreted more calcium 
than those without calculi. In addition, they had 
a higher urinary saturation of calcium oxalate 
and brushite and excreted twice as much calcium 
following a 1-g oral calcium load. As our patients 
had hypercalciuria and nephrolithiasis, it is possible 
that they had higher levels of urinary calcium 
excretion, and thus, needed higher doses of the 
drug to reach normocalciuria. (5) Thiazide diuretics 
can potentially induce metabolic complications, 
especially in long-term treatment, and it is logical to 
consider that these complications are dose related. 
Overall, there is a lack of data on the metabolic 
side effects of thiazide treatment.5 Hypokalemia 
is the main complication that affects hypocalciuric 
effect of hydrochlorothiazide. Hypokalemia 
promotes the proximal reabsorption of citrate, 
which is an inhibitor of calcium oxalate and 
calcium phosphate precipitation. Hypocitraturia 
in the setting of thiazide-induced hypokalemia 
may counter the benefit  of  the decrease in 
urinary calcium.5 Therefore, differences in serum 
potassium levels during treatment might influence 
hypocalciuric effect of the drug. We recommended 
that serum potassium levels be checked every 3 
to 4 months. In addition, to prevent hypokalemia 
and hypocitraturia, we added polycitra-potassium 
to the treatment protocol. 
I think further studies are needed to evaluate 
whether low or high doses of hydrochlorothiazide 
are needed in hypercalciuric nephrolithiasis of 
childhood or hypercaciuria without calculus 
and to identify the effect of treatment on serum 
potassium levels in groups who receive potassium 
citrate in combination with hydrochlorothiazide 
(like our study) as compared to those who receive 
hydrochlorothiazide alone (Choi and colleagues’ 
study). Checking the volume of urine which 
reflects the amount of fluid intake and measuring 
the urinary sodium excretion several times during 
treatment with hydrochlorothiazide are other 
parameters which help to define the role of diet 
in patients who receive the medication.
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